News Room

The post-pandemic landscape has been a challenging one for brick-and-mortar retailers. US Census Bureau data shows that internet sales have grown exponentially in the past 25 years, weighing in at 0.64% in 1999 to accounting for 15.9% of purchases in Q1 2024. 

Economic struggles and too-good-to-be-true value menus go hand in hand.

Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.

Both Amazon and the Transportation Security Administration (TSA) are demanding the biometric data of all Americans.

Too many people in the United States are dying of colorectal cancer (CRC). The #2 cancer killer in the United States, it impacts Black Americans disproportionately. Compared to White adults, Black adults aged 50 and above get colon cancer at a rate that’s 23% higher than White adults and have a 31% higher risk of dying from the disease.1 These disparities persist despite progress in screening and treatment and are particularly frustrating because CRC is highly treatable when caught in early stages and even preventable when pre-cancers are identified and removed through screening. These differences in incidence and mortality persist even while we have made progress to make screening more accessible to all. A 2019 NIH study showed that a similar proportion of Black and White Americans are up to date with CRC screening2, a meaningful improvement since 20053. If screening access and uptake are now so similar, why do these disparities persist?